Eastman Q3 sales up 9% to $2.46 billion; adjusted EPS $2.26 vs $1.47 a year earlier
Eastman reported third quarter 2024 sales of $2.46 billion, up 9% from $2.27 billion a year earlier, with GAAP diluted EPS of $1.53 versus $1.49 and adjusted diluted EPS of $2.26 versus $1.47. The company kept the midpoint of its full-year adjusted EPS guidance unchanged and expects 2024 EPS of $7.50 to $7.70, while saying the Kingsport methanolysis facility has taken longer than expected to reach consistent production rates.
Key points
- Third quarter sales were $2,464 million versus $2,267 million, driven by an 8% increase in sales volume/mix.
- GAAP diluted EPS was $1.53 versus $1.49; adjusted diluted EPS was $2.26 versus $1.47.
- The company expects 2024 EPS of $7.50 to $7.70 and cash from operations of approximately $1.3 billion, with the adjusted EPS guidance midpoint unchanged.
- Eastman made an investment decision to build a second methanolysis facility in Longview, Texas, and returned $195 million to shareholders in the quarter, including $100 million of share repurchases.
The filing
Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 31, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.